Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Multiple sclerosis drugs: Sticker shock.
The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
Remyelination Therapy in Multiple Sclerosis.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Microglia in Health and Disease.
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »